Exane Derivatives’s Tvardi Therapeutics TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
2022
Q1
$10.6K Hold
2021
Q4
$10.6K Hold
2021
Q3
$13.5K Hold
2021
Q2
$11.8K Sell
2021
Q1
$23.6K Sell
2020
Q4
$24.2K Hold
2020
Q3
$20.4K Hold
2020
Q2
$27.4K Hold
2020
Q1
$21.1K Sell
2019
Q4
$136K Sell
2019
Q3
$329K Sell
2019
Q2
$430K Buy
2019
Q1
$133K Sell
2018
Q4
$93.6K Hold
2018
Q3
$172K Hold
2018
Q2
$138K Buy